Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Myriad Genetics revenue
Myriad Genetics's revenue is $183.5 million.
What is Myriad Genetics's revenue?
- Myriad Genetics's revenue growth from 2010 to 2023 is -49.4%.
- Myriad Genetics has 2,600 employees, and the revenue per employee ratio is $70,576.
- Myriad Genetics's peak quarterly revenue was $624.3M in 2025(q2).
- Myriad Genetics peak revenue was $851.1M in 2019.
- Myriad Genetics annual revenue for 2022 was 179.3M, -74.04% growth from 2021.
- Myriad Genetics annual revenue for 2023 was 183.5M, 2.34% growth from 2022.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Myriad Genetics historical revenue
Myriad Genetics's peak revenue was $851.1M in 2019. The peak quarterly revenue was $624.3M in 2025(q2).
Myriad Genetics's revenue increased from $362.6m in 2010 to $183.5M currently. That's a -49.4% change in annual revenue.
Myriad Genetics annual revenue
Myriad Genetics annual revenue over time
| Fiscal year / year | Myriad Genetics revenue |
|---|---|
| 2010 | $362.6M |
| 2011 | $402.1M |
| 2012 | $496.0M |
| 2013 | $613.2M |
| 2014 | $778.2M |
| 2015 | $722.5M |
| 2016 | $740.5M |
| 2017 | $769.9M |
| 2018 | $772.6M |
| 2019 | $851.1M |
| 2020 | $638.6M |
| 2021 | $690.6M |
| 2022 | $179.3M |
| 2023 | $183.5M |
How accurately did Myriad Genetics' revenue projections match actual performance?
Myriad Genetics annual growth
Myriad Genetics saw the greatest revenue growth in 2014, when revenue increased by 26.91%.
Myriad Genetics had the lowest revenue growth in 2022, when revenue changed by -74.04%.
Myriad Genetics annual growth rate over time
| Year | Myriad Genetics growth |
|---|---|
| 2011 | 11%↑ |
| 2012 | 23%↑ |
| 2013 | 24%↑ |
| 2014 | 27%↑ |
| 2015 | -7%↓ |
| 2016 | 2%↑ |
| 2017 | 4%↑ |
| 2018 | 0%↑ |
| 2019 | 10%↑ |
| 2020 | -25%↓ |
| 2021 | 8%↑ |
| 2022 | -74%↓ |
| 2023 | 2%↑ |
Myriad Genetics jobs nearby
Do you work at Myriad Genetics?
Is Myriad Genetics transparent about its revenue structure?
Myriad Genetics financial information
| CEO | Paul J. Diaz |
| Industry | Commercial & Professional Services |
| Company Type | Public |
| Employees Number | 2,600 |
| Date Founded | 1991 |
| Headquarters | Salt Lake City, Utah |
| Number of Locations | 5 |
| Revenue | $183.5M |
| Net Income | -$116,100,000 |
| Gross Proft | $125.7M (2023) |
| PE Ratio | -20.75 |
| Tax Rate | 0.0% |
| Market Capitalization | $2.4B |
| Total Assets | $1,187,200,000 |
| Ticker | MYGN |
Myriad Genetics jobs you might like
Myriad Genetics financing
Myriad Genetics received early financing of $249.4K on 2019.
| Series | Round size | Date |
|---|---|---|
| Equity | $249K | 2019 |
Myriad Genetics competitors
Myriad Genetics's top competitor, Gilead Sciences, earned an annual revenue of $28.8B.
Myriad Genetics's smallest competitor is Davison with revenue of $590.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Sarepta Therapeutics | $94,985 | $1.9B | 840 | 24 |
| Alnylam Pharmaceuticals | $81,014 | $2.2B | 1,323 | 1 |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 562 |
| Seagen | $85,008 | $2.0B | 900 | - |
| ZymoGenetics | $90,249 | $27.0M | 200 | - |
| Exelixis | $108,978 | $2.2B | 484 | 167 |
| GlobeImmune | $49,176 | $6.5M | 22 | - |
| Neurocrine Biosciences | $78,232 | $2.4B | 400 | 409 |
| Geron | $56,851 | $77.0M | 15 | - |
| Ligand Pharmaceuticals | $82,001 | $241.5M | 116 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Myriad Genetics highest paying jobs
Zippia gives an in-depth look into the details of Myriad Genetics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Myriad Genetics. The employee data is based on information from people who have self-reported their past or current employments at Myriad Genetics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Myriad Genetics. The data presented on this page does not represent the view of Myriad Genetics and its employees or that of Zippia.
Myriad Genetics may also be known as or be related to MYRIAD GENETICS INC, Myriad Genetics, Myriad Genetics Inc, Myriad Genetics Inc. and Myriad Genetics, Inc.